QUICKLINKS AND VIEW OPITONS
Obesity, insulin resistance and diabetes associated more than 20 degenerative diseases
Saturday, June 05, 2004 2:44 am Email this article
Obesity, diabetes, insulin resistance, and excessive or impaired insulin secretion are associated with more than 20 degenerative diseases according to a new paper from the German Institute for Human Nutrition, in Nuthetal-Berlin, Germany.
These conditions include:
- Alzheimer disease
- Parkinson disease
- Down syndrome
- mitochondrial disorders
- vitamin B1 (thiamine) deficiency
- Huntington disease A progressive disorder involving wasting (degeneration) of nerve cells in the brain. Huntington’s disease is an inherited condition characterized by abnormal body movements, dementia, and psychiatric problems. The disorder was first described in 1872 by George Huntington, an American physician.
- Prader-Willi syndrome Babies with Prader-Willi syndrome are born with low muscle tone and a weak sucking reflex. Once the muscles strengthen, however, their insatiable appetite takes over. They eat and eat, never feeling full. As they have a lower metabolism than normal people, they often end up obese if the kitchen isn’t locked. This is caused by a misdevelopment of the hypothalamus. This genetic disorder was discovered in 1956 by Andrea Prader, Heinrich Willi, Alexis Labhart, and Guido Fanconi of Switzerland.
- Werner syndrome A rare, genetic disorder who’s most recognizable characteristic is premature aging. For this reason, Werner syndrome is often referred to as a progeroid syndrome, as it partly mimics the symptoms of progeria. Individuals with Werner syndrome age rapidly following puberty, so that by the time they reach age 40 they often appear as though they are many decades older. Patients with Werner sydrome also exhibit age-related disorders include cancer, heart disease, atherosclerosis, diabetes mellitus, and cataracts. However, not all characteristics of old-age are present in Werner patients; for instance, senility is not seen in individuals with Werner syndrome. The average age at death of Werner patients is 47, usually as a result of cancer or heart disease. Werner syndrome is an exceedingly rare disorder, with some estimates suggesting that it afflicts approximately 1 in 1,000,000 individuals worldwide. Some populations do seem more suceptible to Werner syndrome, however, including individuals of Japanese decent. The gene responsible for Werner syndrome was identified in 1996 and named WRN.
- Wolfram syndrome A genetic disorder characterized by type 1 insulin-dependent diabetes mellitus, diabetes insipidus, optic atrophy and a number of neurological symptoms including deafness, ataxia, and peripheral neuropathy. This is a progressive neurodegenerative disorder, and many subjects also develop urinary tract atony, ataxia, peripheral neuropathy, and psychiatric illness.
- Friedreich ataxia Ataxia is a condition marked by impaired coordination. Friedreich’s ataxia is an inherited, progressive nervous system disorder causing loss of balance and coordination. Friedreich’s ataxia is the most common inherited ataxia, affecting between 3,000-5,000 people in the United States. Two defective gene copies must be inherited to develop symptoms, one from each parent.
- myotonic dystrophy A severe form of muscular dystrophy marked by generalized weakness and muscular wasting that affects the face and feet and hands and neck; difficult speech and difficulty with the hands that spreads to the arms and shoulders and legs and hips; the onset can be any time from birth to middle age and the progression is slow.
- ataxia-telangiectasia A disease characterized by loss of muscle control, and reddening of the skin caused by a defect in DNA repair mechanisms induced by radiation.
PRELIMIARY CONCLUSIONS: CAUSED BY ALTERATIONS IN ENERGY PRODUCTION
Prelimiary conclusions suggest that many of these disorders are related to alterations in energy production in the body—an alteration of a process known as oxidative phosphorylation which converts ADP into ATP, the “universal energy molecule”—and metabolisms of nutrients by the mitochondria.
Ristow M. Neurodegenerative disorders associated with diabetes mellitus. J Mol Med. 2004 Jun 3 (published early on the web).
Comment: There was a fascinating article published in the October 2002 issue of Discover magzine about the research being conducted by University of California at Berkeley biochemist Bruce Ames, Ph.D. which I believe may partial related to the above aritcle.
Ames discovered that giving the equivalent of 500 mg of acetyl-L-carnitine plus 200 mg of alpha lipoic acid twice a day to aging mice, which improved the functioning of their old mitochondria, doubled their activity level and improving their memory of old rats to nearly that of young rats.
Ames also believes that high amounts of B vitamins can boost levels of coenzymes, thereby improving the function of defective enzymes.
It seems possible to me that nutrients such as these might help to alleviate some of the diseases list above associated with obesity, insulin resistance and diabetes, although I imagine it will be years before any such studies are conducted.
One reason I say this is that nutrients which are involved in aspects of energy production, such as high doses of coenzyme Q10, have been found to slow the progression of Parkinson Disease (one of the conditions listed above as being associated with obesity, insulin resistance and diabetes) by as much as 44 percent.
Below is the article from Discover magazine about Dr. Bruce Ames.
Note: Larry Hobbs added subheadings to article below to make it easier to read.
Vol. 23 No. 10
By Karen Wright
Photography by Misha Gravenor
The eminent, controversial, and endlessly inventive biochemist Bruce Ames thinks he has found a way to slow the aging process in the brain. May the force be with him.
GETTING OLD IS LIKE GETTING IRRADIATED
“Getting old is just like getting irradiated,” says Bruce Ames, whose quest during the twilight of his career is to find ways to combat???and possibly reverse???the destructive effects of ordinary cellular metabolism.
IF THE EPA ELIMINATES PESTICIDES, THERE WILL BE MORE CANCER
As the California sun descends on an afternoon social of wine, cheese, fruit punch, and Ping-Pong, National Medal of Science-winner and University of California at Berkeley biochemist Bruce Ames extols the virtues of pesticides to a former student. Pesticides allow fruits and vegetables to be produced more cheaply, he says, which means more poor people can afford to eat them. Poor people are most at risk for cancer, heart disease, and other ailments linked to diets low in fruits and vegetables. Hence, in the world according to Ames, pesticides confer a public-health advantage that far outweighs any health risk posed by their noxious residues. “If the EPA eliminates all the pesticides,” he says, “all it’s going to do is increase the price of fruits and vegetables, and there will be more cancer.”
“Isn’t he great?” the student gushes.
It’s a typical reaction. Time and again in the course of his career, Ames, 73, has managed to deliver unpopular and even preposterous messages without denting his own credibility. Slender and mild-mannered, favoring striped shirts and cardigans, he has the bearing of a favorite uncle at a family reunion who tells silly jokes: “When I feel like exercise, I run my experiments, I skip controls, and I jump to conclusions.”
AMES INVENTED AMES TEST TO INDENTIFY CANCER-CAUSING CHEMICALS
His track record helps silence detractors. Ames invented a simple test in the 1960s to identify cancer-causing chemicals that is still used worldwide. He has collected top honors in his field, published more than 450 scientific papers, and become one of the most cited scientists alive.
AMES IS NOW STUDYING DIETARY SUPPLEMENTS TO HELP WITH PHYSICAL AND MENTAL REJUVENATION
Now Ames has decided to take on the most brow-raising research of his career: a scheme for physical and mental rejuvenation that relies mostly on common dietary supplements. His research group at Berkeley and at the nearby Children’s Hospital Oakland Research Institute has discovered a simple recipe that makes old rats think and act more like young ones. “If I’m lucky,” Ames says, “we’ll add a few years to human lives with this research.”
But luck is only one ingredient in Ames’s success. He describes himself as a big-picture person, a so-so student who somehow made good in academia by assembling the byzantine details of other scientists’ insights into coherent wholes. He never mentions hard work. Although well past the age of retirement, Ames still lives for the lab. “I told a friend that I was doing the best work of my career,” he says, “and he said I had been telling him that for 30 years.”
AMES BEGAN AT THE NIH WHERE HE DEVELPED THE AMES TEST
In the 1950s, Ames began working at the National Institutes of Health, where he was investigating ways of mutating the DNA of bacteria in order to learn more about gene regulation. His work led him to develop a petri-dish protocol for testing whether a substance can cause such mutations. With that test, Ames and other investigators were able to show that most cancer-causing chemicals act by damaging genes???a finding that now seems obvious only because Ames helped prove it. “This test you can do in an afternoon, whereas an animal cancer test costs a million dollars and takes two years to do,” he says. “I never patented it, so I never made any money out of it.”
IN THE 1960???S HE WENT TO U.C. BERKELEY WHERE HE CONTINUED TO STUDY CANCER
But Ames had made a reputation. In the late 1960s, he took that reputation to Berkeley, where he continued his cancer studies. In one of his classes, he invited students to run the Ames mutagenicity test on substances they routinely used. “They would bring in birth control pills, marijuana, things that were interesting to them,” he says. “But one day, one of the students brought in hair dye. And it was screamingly mutagenic.” Ames identified the culpable compounds, and dye manufacturers eliminated them. He went on to demonstrate that the flame-retardants then used in children’s clothing were also mutagens.
A concerned young mother named Lois Gold contacted Ames after his findings were reported in the local paper. Impressed by her questions and her background in statistics, Ames hired her to help him create an exhaustive compendium on the toxicity of everyday and industrial chemicals. “She didn’t know anything about science, but she was very logical and very persistent, wanting to know every little thing,” he recalls. “I like people around me who want every i dotted and t crossed.” The carcinogenic potency database has become an institution, and Gold still runs it.
HALF OF ALL CHEMICALS, NATURAL OR SYNTHETIC, CAUSE CANCER IN HIGH ENOUGH DOSES
But as Ames reviewed the results of animal tests for the database, his stance on cancer-causing chemicals shifted. He and Gold have shown that half of all chemicals, whether natural or synthetic, cause cancer in animals if they are delivered in high doses. Mold toxins, plant-made pesticides, and compounds in roasted coffee, for example, test positive in rodent carcinogen assays. Yet people are rarely subjected to such extreme levels. Ames came to believe that too much of anything, even a good thing, might stress a body enough to cause cancer. The high doses of compounds used in tests on rats, he says, are therefore meaningless.
“Nobody ever really did the controls???they didn’t test a random set of natural chemicals,” he says. “We think half the chemicals in the world are going to be carcinogens when you test them at these huge doses. So what we’re saying is not that natural chemicals are particularly dangerous, but that those are most of the chemicals you get into you, and the hit rate is exactly the same.”
MORE LIVES WOULD BE SAVED IF MONEY SPENT ON EFFORTS TO STOP SMOKING AND IMPROVE NUTRITION
Nor is Ames saying that all man-made chemicals are safe; he just thinks public health priorities have become skewed. More lives would be saved, he insists, if the money spent on regulating pesticides and industrial waste were channeled instead into campaigns to eliminate smoking and improve nutrition. “I just view it all as some terrible distraction,” he says. “People are being done in by their own behavior: eating, drinking, smoking.”
“I don’t think anyone will deny that diet is important,” says Ronald Melnick, a toxicologist at the National Institute of Environmental Health Sciences who has coauthored a lengthy rebuttal of Ames’s claims. “But what he says is: ‘Eat your spinach, and don’t worry about whether there’s pesticide on it.’ But why not eat very low levels of pesticide on your spinach? You can have both.” Affordable produce grown with pesticides, Melnick says, could be made safer if farmers or consumers got serious about washing off chemical residues. “It’s not a matter of one or the other. We need to address both issues.”
Melnick also argues that animal studies include doses at various levels in order to establish cause and effect. “It’s an overgeneralization to say that every study is done at high doses. We try to make a judgment of what dose could be used without causing significant tissue damage. It’s not just a matter of pumping in as much as you can.” In any case, Melnick and his colleagues say, there’s no alternative to animal testing, short of waiting 30 years to see if people exposed to suspect chemicals get cancer.
Harvard University epidemiologist Walter Willett says Ames is “obviously playing a role???and somebody in science has to do it???where sometimes you need to state things provocatively to stir up the pot and get people to look critically at issues they weren’t looking at before.”
Mitochondria are the structures in which the chemical reactions that power a cell occur, and they undergo age-related damage from metabolism. When comparing a young rat’s brain cell (above) with an old rat’s brain cell (below), the deterioration of mitochondria???the large sausage-shaped objects???is visibly apparent. A human brain cell may house well over a thousand mitochondria. Each one reproduces independently and lives for about two weeks.
Photographs courtesy of Dr. Jiankang Liu.
AT AGE 65, AMES SWITCHED TO STUDYING AGING
As Ames neared 65, his thoughts turned to the notion of aging. He wasn’t contemplating retirement, grandchildren, or Palm Beach. His studies of cancer-causing chemicals had instead led him to consider a group of substances that often prove troublesome to folks of his vintage: free radicals.
Free radicals are highly reactive molecules that ravage the innards of cells. Free refers to the fact that these compounds are misfits, with no proper place in cellular society. Radical is the name biochemists give to an atom or molecule with an unpaired electron. Unattached free radicals bond indiscriminately with other molecules, stripping them of electrons with disastrous results???broken chromosomes, crippled enzymes, and punctured membranes. The electron-stripping process is called oxidation, and in controlled circumstances it’s a vital part of ordinary cellular metabolism.
But free radicals are more like toxic waste. They leak from energy-making organelles called mitochondria; they spew from disease-fighting blood cells. Although cells have built-in mechanisms for cleaning up free radicals, the oxidants ultimately get the upper hand. In the mid-1950s, Denham Harman, a physician and chemist in the Donner Laboratory of medical physics at Berkeley, proposed that the cumulative damage wreaked by free radicals was largely responsible for the aging process. Today his free-radical theory is the most widely accepted model of aging.
FREE RADICALS CAN BREAK DNA, CAUSE CANCER
Ames got interested in free radicals because they can cause cancer. Like radiation and carcinogens, free-radical oxidation breaks strands of DNA. The breaks are repaired, but some mistakes occur. Mistakes in DNA coding are also known as mutations. And as Ames had helped demonstrate, certain genetic mutations predispose an individual to certain cancers. No one knows why, but the incidence of most cancers increases with age. Ames thought the age-related increase in cancer rates might have something to do with an age-related rise in oxidative damage to DNA.
1990 AMES DISCOVERED DNA OXIDATION INCREASES WITH AGE
But no one had shown that DNA oxidation actually does increase with age. In 1990 Ames and his colleagues at Berkeley published the first evidence that it might. They found twice as much DNA oxidation in the tissues of 2-year-old rats as in those from 2-month-old rats.
MITOCHONDRIA MAKE KILOS OF OXYGEN RADICALS PER YEAR
Ames’s research on oxidation led him to look more closely at mitochondria because they are the mother lode of free radicals. In order to burn fats and carbohydrates to make metabolic fuel, mitochondria take electrons from oxygen and shuffle them among a suite of molecules in a complex chain reaction. Invariably, some of the electrons get misplaced, creating free radicals. “People have estimated that [the electron transport chain] is maybe 98 percent efficient, which is much better than a human engineer can do,” says Ames. “But it still makes kilos of oxygen radicals per person per year.”
MITOCHONDRIA PRODUCE MORE OXIDANTS THAN ANY OTHER SITE IN CELL
Mitochondria produce more oxidants than any other single site in a cell, the main offenders being superoxide, hydrogen peroxide, and hydroxyl radicals. Ames thought mitochondria would therefore be hardest hit by free-radical damage, not only to mitochondrial DNA but also to enzymes in the electron transport chain and lipids in mitochondrial membranes.
OLD MITOCHONDRIA ARE LESS EFFICIENT
It also occurred to him that mitochondria might be an ideal target for intervening in the aging process. Working with postdoctoral student Tory Hagen, Ames characterized the changes that occur in the mitochondria of aging rats. They have shown that old mitochondria consume less oxygen, have stiffer membranes, and shuffle electrons less efficiently than their younger counterparts. Old mitochondria also make a lot more oxidants.
AMES???S WIFE IS ITALIAN, AND THEY OWN A HOUSE IN TUSCANY
If he chose to, Bruce Ames could trace his next antiaging breakthrough to a decision he’d made 40 years before, when he proposed to Giovanna Ferro-Luzzi, who was then a biochemist at the National Institutes of Health. Ames is still madly in love with his wife and with her native country. The couple own a house in Tuscany and an apartment in Rome.
AMES NOTICED ACETYL-L-CARNITINE SOLD AS A “PICK-ME-UP” IN ITALY
In the mid-1990s, a dietary supplement called acetyl-L-carnitine became all the rage in Italy. Ames took notice. “It sold as a pick-me-up. You’d think Italians would get picked up with espresso,” he says.
ITALIAN RESEARCHERS FOUND ACETYL-L-CARNITINE IMPROVED FUNCTION OF OLD MITOCHONDRIA, HELPS TO SHUTTLE FAT INTO MITOCHONDRIA
Researchers at the University of Bari in Italy had reported that feeding acetyl-L-carnitine to old rats improves the function of their mitochondria. Stateside, no one but Ames paid much attention to the report. He could see how the supplement might achieve its effects: Acetyl-L-carnitine, also known as Alcar, is a nutrient that helps transport fatty-acid fuel across lipid membranes into mitochondria. Thus the more Alcar a cell has, the better its mitochondria might function.
AMES GAVE ACETYL-L-CARNITINE TO OLD RATS, IMPROVED FUNCTION, BUT MORE RADICALS
Ames reasoned that high levels of Alcar might also combat the problems of aging membranes and decrepit enzymes. He began feeding Alcar to his old rats. Within weeks, he and Hagen noticed improvements in the animals’ biochemistry and behavior. Their mitochondria were going full bore again, and they had become far more active. But the old rats were still churning out oxidants at a very high rate. In fact, by goosing metabolism, Alcar seemed to slightly increase free-radical production. “We didn’t solve the problem of oxidants,” Ames says. “In fact, if anything, it was a little worse.”
ACETYL-L-CARNITINE PLUS ALPHA LIPOIC ACID BETTER THAN EITHER ALONE, IT DOUBLED OLD RATS ACTIVITY LEVEL
Ames decided to add an agent to the rats’ diet to neutralize the oxidants. He tried lipoic acid, a mitochondrial antioxidant. The results were profound. Oxidants and oxidative damage to mitochondrial components dropped dramatically. Both the structure and function of the mitochondria improved. The rats’ activity levels doubled. They were, Ames says, “doing the Macarena.” The combination of the nutrient and the antioxidant had a synergistic effect. “The two together are better than either one alone.”
ACETYL-L-CARNITINE PLUS ALPHA LIPOIC ACID IMPROVED MEMORY OF OLD RATS TO THAT NEARLY OF YOUNG RATS
But the most exciting changes were in the rats’ brains. Ames, Hagen, and another postdoc, Jiankang Liu, tested the memory of old rats by training them to find a platform submerged in a swimming tank. Rats are good but reluctant swimmers, so they’re motivated to learn. Without supplementation, “the old ones are wandering all over the place before they find the hidden platform,” Ames says. “The young ones make a beeline for it.” With just a month of Ames’s antiaging combo, old rats get to the platform almost as fast as young ones. The old rats’ performance on other kinds of memory tests also improves, showing that the swimming-tank test isn’t just measuring sharper eyesight. Ames is waiting to see whether they live longer too.
TUNING UP OUR BIOCHEMISTY WITH SUPPLEMENTS
Ames believes that his team’s studies of the effects of dietary supplements in aging rats could lead to a new appreciation of nutrition. “I’m very excited about the idea of tuning up our biochemistry???someday it may be as big a thing as pharmaceuticals.”
So far, Ames’s latest project has been greeted with less skepticism than might be expected. “It was surprising to a lot of people, but it’s something that he has documented well,” says Earl Stadtman, an expert on protein oxidation and aging and a former colleague of Ames’s at the National Institutes of Health. “I don’t think there’s any reason to doubt [his findings]???I don’t doubt anything that Bruce does, because I’ve followed his research over the years, and it’s been very solid.”
500 MG OF ACETYL-L-CARNITINE PLUS 200 MG OF ALPHA LIPOIC ACID TWICE A DAY
The public may soon be conducting its own reviews. Three years ago, Ames set up a company called Juvenon to test the antiaging duo in human beings. But it’s not exactly a proprietary blend. Both ingredients???Alcar and lipoic acid???are already marketed as dietary supplements. Consumers can even duplicate the dosages used in Juvenon’s trials: 200 milligrams alpha-lipoic acid and 500 milligrams acetyl-L-carnitine, twice a day.
“There’s nothing to prevent a health-food store from putting a bottle of acetyl-L-carnitine on a shelf, putting a bottle of lipoic acid next to it, and putting our paper up above it,” Ames admits. But in this country, dietary supplements are not tightly regulated to ensure that the products contain the advertised doses and ingredients. And Ames won’t know the optimal dose of each supplement until the trials’ completion. Meanwhile, he’s identified other common nutrients that may also reverse aging. “There will be other things to add to this mixture,” he says. “This is just the beginning of getting a really good aging-intervention therapy.”
B-VITAMINS MAY COMBAT MIGRANES, MENTAL RETARDATION, AND OTHER MALADIES
Ames is convinced that simple B vitamin therapy could also combat some cases of migraines, mental retardation, and many other maladies. In a subset of patients with each disease, Ames believes the same underlying mechanism is at work: Genetic mutations result in deformed enzymes that don’t work as well as normal ones. Enzymes rely on molecular partners called coenzymes to do their job. High amounts of B vitamins can boost levels of coenzymes, thereby improving the binding function of defective enzymes.
NO LESS THAN 50 GENETIC DISEASES MIGHT BE REMEDIED WITH HIGH DOSES OF VITAMINS, MINERALS, AND AMINO ACIDS
Ames has published an exhaustive review, with more than 300 references, showing that no fewer than 50 genetic diseases might be remedied with high doses of vitamins, minerals, and amino acids. “He’s pulled together a lot of information from different fields,” Willett says. “This is going to keep 500 scientists working hard for the next 50 years in order to sort it all out.”
NIACIN MIGHT HELP JAPANESE TOLERATE ALCOHOL
True to his role as provocateur, Ames likes to illustrate the enzyme concept with a somewhat preposterous example. Half of all Asians can’t tolerate alcohol, he notes, because of a hereditary deformation in an enzyme that regulates alcohol metabolism. That enzyme relies on a helper molecule called NAD that, in turn, contains dietary niacin. Treatment with niacin increases NAD levels and might overcome the enzyme deficiency. “I know you can feed people high niacin and raise NAD levels,” says Ames, “but no one else knows it. I thought briefly of patenting a Japanese beer with niacin. You could get all the Japanese drunk.”
HE RECOMMENDS A HEALTHY DIET AND A DAILY MULTIVITAMIN
In the future Ames envisions, people will be screened individually for genetic mutations and micronutrient deficiencies, and dietary interventions will be customized. Ames and his colleagues have already devised a DNA test that can quickly assess oxidative damage to a person’s genes. But those tests aren’t cheap, and multivitamins are. As a more practical measure, he recommends a healthy diet and a daily multivitamin; he takes one every day himself. “To do an analysis on each person would cost hundreds of dollars, and yet it’s a penny for a multivitamin,” he says.
AMES DOES NOT STAND TO PROFIT FROM HIS IDEAS
Ames doesn’t stand to profit either way. He has no financial stake in Juvenon, and Berkeley gets most of the proceeds from his patents. But Ames unwittingly assured himself a pension several years ago when he wrote a $100,000 check to a former student who was starting a biotech company in California. The company sold for $100 million in 2000. Ames gave $8 million of his newfound wealth to start a genomics and nutrition center. He gave his department at Berkeley a couple million for improvements there, and he doled out thousands more to research projects. With the rest, he set up a foundation to conduct outreach programs to improve nutrition among the poor. “If I’m going to get vitamins in the poor, I guess I’m going to have to do it myself,” he says.
AMES GOAL IS TO EXTEND FUNCTIONAL YEARS
Meanwhile, he says his goal is to extend functional years rather than longevity per se. Yet when he strays from his discourse on mitochondrial membranes and antioxidants, he gives the impression that the secret to his own long, happy history doesn’t come from a pill bottle.
WHO NEEDS MONEY?
“I’m so content, I’m just purring in my life now,” he says. “I have a wonderfully happy marriage. I’m doing very well in my career. And then I just got all this money. But who needs money?”
Articles on the same subject can be found here:
On Mar 14, 2005 at 8:06 am Randy Smith, MD wrote:
. . . . .
I agree with the use of acetyl-l-carnitine and alpha lipoic acid. I recommend this combination in my antiaging practice. Many of the chronic diseases of aging have a mitochondrial component and are in a sense mitochondrial diseases.
On Mar 14, 2005 at 8:25 am Larry Hobbs wrote:
. . . . .
A personal observation about alpha lipoic acid.
I've taken acetyl-L-carnitine and alpha lipoic acid for 5 years.
Last June 2004, after writing an article about how large doses of alpha lipoic acid causes "profound weight loss in rodents", I decided to increase my dose.
The article can be found here:
I double my dose from 250 mg twice a day to 500 mg twice a day, then tripled my dose to 750 mg twice a day, then quadrupled my dose to 1000 mg twice a day.
I then switched from R,S-alpha lipoic acid to R-alpha lipoic acid which is the active form, which seems to be at least twice as potent mg for mg.
I definitely noticed more energy and sweating more while playing basketball as I increased the dose.
However, I also developed a cough that would not go away. It lasted for weeks. I assume it was a respiratory infection.
I did some research and found that alpha lipoic acid inhibits the enzyme that converts the storage form of thyroid hormone, T4, to the active form, T3.
Low thyroid function is associated with an increased risk of infections.
I assume alpha lipoic acid may reduce T3 in order to prevent overstimulation.
I also assume that the increased dose of alpha lipoic acid reduced my levels of T3 thyroid hormone which allowed a respiratory infection to take hold and my body not able to fight it off.
So after several weeks, maybe even two months, I finally reduced my dose of alpha lipoic acid back to the original form of R,S and reduced the dose back to the original level of 250 mg twice a day.
However, I then found it difficult to get a sweat going while exercising. This lasted for months.
The point of the story is that, according to my experince, large doses of alpha lipoic acid may lower T3 thyroid hormone levels and increase the risk of infection.
Please feel free to share your comments about this article.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.